Pacegenix
Cambridge, US · Founded 2024 · Delaware corporation · 1 known investors
Founders & leadership
JG
Jay Glenn WohlgemuthExecutive
FG
Frank Grazzini, IIExecutive
Board
FN
Fredric Neville EshelmanBoard director
RT
Raymond TabibiazarBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 1 round · 2026
▶$22.5MraisedMar 2026 · 15 investors · BiotechnologyRule 506(b)
▶$22.5MraisedMar 2026 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay Glenn WohlgemuthExecutive Officer, Director
- Fredric Neville EshelmanDirector
- Raymond TabibiazarDirector
- Frank Grazzini, IIExecutive Officer
- Offering amount
- $22.5M
- Amount sold
- $22.5M
- Sales commissions
- $577.5K
- Proceeds to insiders
- $600K
- Placement agents
- LifeSci Capital, LLC
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pacegenix's investors?
- Pacegenix's investors include aMoon.
- How much funding has Pacegenix raised?
- Pacegenix has disclosed $22.5M raised across 1 round.
- Where is Pacegenix headquartered?
- Pacegenix is headquartered in Cambridge, US.